The largest database of trusted experimental protocols

Plko 1 puro vector

Manufactured by Thermo Fisher Scientific
Sourced in United States

The PLKO.1-Puro vector is a lentiviral vector designed for the stable transduction of cells. It contains a puromycin resistance gene, allowing for the selection of successfully transduced cells. The vector's core function is to enable the integration of genetic material into the host cell's genome, facilitating long-term transgene expression.

Automatically generated - may contain errors

7 protocols using plko 1 puro vector

1

ORC1 Overexpression and Silencing Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The full-length cDNA encoding human ORC1 was amplified through polymerase chain reaction (PCR) and inserted into a pMSCV-puro-retro vector (TaKaRa, Kusatsu, Shiga, Japan) by cloning. Subsequently, two short hairpin RNAs (shRNAs) targeting ORC1 were cloned into the pLKO.1-puro vector (Invitrogen, Waltham, MA, USA). Specific regions of ORC1 promoter sequences were amplified using PCR and cloned into a luciferase reporter plasmid. The transfection of the plasmids into the designated cells was performed using Lipofectamine 3000 (Invitrogen, Waltham, MA, USA). To establish stable cell lines, retroviral or lentiviral infection was employed to express Flag-ORC1 or ORC1-shRNA, respectively. Following a 10-day culture period, the cells were selected using 0.5 μg/mL puromycin. Double-strand oligos of sh-ORC1: 5′-CACCAGTTTTCGATCCAACAAGGGCCGAAGCCCTTGTTGGATCGAAAAC-3′.
+ Open protocol
+ Expand
2

Modulating MYBL2 Expression in Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Full-length cDNA encoding human MYBL2 was PCR-amplified and cloned into a pMSCV-puro-retro vector (TaKaRa). To silence endogenous MYBL2, two short hairpin RNA (shRNA) oligonucleotide sequences targeting human MYBL2 were constructed into the pLKO.1-puro vector (Invitrogen). Different regions of the human MYBL2 promoter sequences generated by PCR amplification were cloned into the pGL3 luciferase reporter plasmid (Promega) to construct the corresponding luciferase reporters. A site-specific mutagenesis kit (Stratagene) was used to synthesize promoter reporter constructs with mutations in the MYBL2-binding motif. Transfection of plasmids was performed using Lipofectamine 3000 (Invitrogen) according to the manufacturer's protocol. Stable cell lines expressing MYBL2 or MYBL2-shRNA were generated by retroviral or lentiviral infection, respectively, and selected with 0.5 μg/mL puromycin after a 10-day culture period. Cells infected with the pGL3 luciferase retrovirus were selected with 250 μg/mL G418.
+ Open protocol
+ Expand
3

Generating Vinexin and CAP Knockdown/Rescue Constructs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The small hairpin RNA for vinexin (#1 5′-GGTGAACGAACATTGGTATGA-3′, or #2 5′-CGGCTCAGGCTTTGTGATGATGG-3′) or CAP (#1 5′-GGACCTCCTCAATATAGATGA-3′, or #2 5′-GGAGACGTTGTTTACATCTAC-3′) were subcloned into pLKO.1-Puro vector from Open Biosystems (Huntsville, AL). Expression plasmids containing mouse vinexin α/β and CAP cDNA were described previously4 (link),18 (link). The cDNAs encoding vinexin and CAP resistant to shRNAs were generated by site-directed mutagenesis using In-Fusion® HD cloning kit (Clontech, Mountain View, CA) and subcloned into pCDH-EF1-IRES-hygro vector from System Biosciences (Mountain View, CA). Generation of monomeric GFP-tagged vinculin T12 mutant were described previously16 (link).
+ Open protocol
+ Expand
4

Transient and Stable FOXO3a Transfections in Ph+ Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
For transient transfections, pECE-FOXO3aWT or FOXO3aTM (Addgene, Cambridge, MA) containing wild-type FOXO3a (FOXO3a WT) or a mutant form insensitive to AKT phosphorylation (FOXO3a TM) (T32A/S253A/S315A) 30 (link), respectively, were electroporated into Ph+ K562, KCL22, or primary CD34+ cells using the Amaxa Nucleofector Kit V (Lonza, Wolverhampton, UK) following the manufacturer's instructions. For stable transfections, FOXO3a WT and TM were subcloned into pcDNA 3.1 zeo and transfected into Ph+ K562 cells as above and stable cells selected in 200 µg/ml zeocin (Invitrogen). FOXO3a sh-RNA was subcloned from the pLKO.1 puro vector (Open Biosystems) into pLKO.1 GFP vector. The same approach was used to transfect Ph+ K562 with pLKO-GFP-FOXO3a and pLKO-GFP-scrambled control. After 24 hours, the cells were sorted based on green fluorescent protein (GFP) expression using a FACS ARIA Flow Cytometer sorter (Becton Dickinson).
+ Open protocol
+ Expand
5

Lentiviral shRNA-Mediated CYBA Knockdown

Check if the same lab product or an alternative is used in the 5 most similar protocols
CYBA (gene encoding p22phox) knockdown was performed by lentiviral transduction of shRNA as previously described.31 (link), 32 (link) Briefly, lentiviral shRNA constructs in the pLKO.1 Puro vector (Open Biosystems, Thermo Fisher Scientific) were ordered. Targets (sense) used for these studies were scrambled control (Ctrl) 5’- GTCTCCGAACGTGT CACGTT-3’ and CYBA (TRCN0000064581) 5’-CGCTTCACCCAGTGGTACTTT-3’. 3.5×106 HEK293T cells, which were used to generate viral particles, were plated on a tissue culture treated 10cm dish the day before transfection. One 10cm plate was transfected per shRNA construct by the calcium phosphate method using the following constructs: 6 μg control or CYBA shRNA construct, 0.6 μg vesicular stomatitis virus (VSV-G), and 5.4 μg cytomegalovirus (CMV 8.9.1). Supernatant was collected after 72 hr. and centrifuged to remove debris. 1×106 PLB-985 were mixed with the viral supernatant in the presence of 4 μg/ml polybrene in a 6 well plate and centrifuged at 1000× g in a swinging bucket centrifuge for 30 minutes at 32°C. Stable lines were created by selection of transduced cells with 1 μg/ml puromycin.
+ Open protocol
+ Expand
6

Stable Cell Lines for Zinc Transporter Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stable cells with decreased expression of ZnT1 (SLC30A1) and ZnT4 (SLC30A4) were generated by lentivirus-mediated shRNA expression. The pLKO.1-Puro vector expressing shRNA sequences targeting ZnT1 (target sequence of 3 clones: CCTGCAAAGCATTTGTAGAAA, GCTACTACCATTCAGCCTGAA, and GAAGTACAAGTGAATGGAAAT), and ZnT4 (target sequence of 3 clones: CATACGATTCAAGCCAGAATA, CATAGTTCACATACAGCTAAT, and TATGGGATACAGTAGTTATAA) were obtained from OpenBiosystems, and viruses were generated at the Department of Urology of the UT Southwestern Medical Center. Polyclonal pooled populations of stable cells were selected in the presence of puromycin (2 μg/ml) for more than 3 passages before initiating any functional experiments. Western blot was performed for evaluate the knockdown efficiency of shZnT1 and shZnT4 (Figure S1).
+ Open protocol
+ Expand
7

Tcea3 mRNA Knockdown via shRNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were transfected with scrambled control or Tcea3 mRNA specific shRNA constructs designed by the RNAi Consortium (TRC) in the pLKO.1 puro vector (Open Biosystems). Five constructs targeting Tcea3 mRNA (shTcea3) were transfected using the TurboFect transfection reagent (Thermo Scientific) according to manufacturer’s protocol. Protein and RNA were harvested 48 hours post shRNA transfection or selected for stable cell lines with puromycin (2 μg/ml). Selected colonies were grown and validated for depletion.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!